Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

61°
- Newport, VT (05855)
  Today
  
  Cloudy skies with a few showers this afternoon. High near 75F. Winds light and variable. Chance of rain 30%..
  
  Tonight
  
  Mostly cloudy skies during the evening. Areas of fog developing after midnight. Low 59F. Winds light and variable.
  
  Updated: July 30, 2026 @ 4:41 am
- Full Forecast

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NGM Biopharmaceuticals, Inc. - Common Stock (NQ:NGM)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 4, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NGM Biopharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday ↗

October 21, 2022

Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million...

Via Benzinga

US Stocks Turn Lower; Dow Tumbles Over 100 Points ↗

October 20, 2022

U.S. stocks turned lower toward the end of trading, with the Dow Jones dropping more than 100 points on Thursday.

Via Benzinga

Where NGM Biopharmaceuticals Stands With Analysts ↗

October 18, 2022

Within the last quarter, NGM Biopharmaceuticals (NASDAQ:NGM) has observed the following analyst ratings:

Via Benzinga

4 Analysts Have This to Say About NGM Biopharmaceuticals ↗

October 18, 2022

Within the last quarter, NGM Biopharmaceuticals (NASDAQ:NGM) has observed the following analyst ratings:

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 20, 2022

Gainers

Via Benzinga

Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session ↗

October 20, 2022

Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.

Via Benzinga

Analyst Ratings for NGM Biopharmaceuticals ↗

October 18, 2022

NGM Biopharmaceuticals (NASDAQ:NGM) has observed the following analyst ratings within the last quarter:

Via Benzinga

NGM Bio Plunges As Experimental Drug Fails To Meet Primary Goal In Age-Related Vision Loss Disorder ↗

October 17, 2022

Via Benzinga

NGM Bio Presents Preliminary Data From NGM120 Combo Trial In Pancreatic Cancer ↗

September 14, 2022

Via Benzinga

Nasdaq Rises Over 100 Points; Crude Oil Up 1.5% ↗

October 20, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday.

Via Benzinga

Short Volatility Alert: NGM Biopharmaceuticals, Inc. ↗

October 20, 2022

On Wednesday, shares of NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) experienced volatile short activity. After the activity, the stock price went down -0.81% to $3.69. The overall sentiment for NGM has...

Via Benzinga

$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

October 20, 2022

The Dow Jones dropped by around 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Dow Rises Over 2%; S&P 500 Up 100 Points ↗

October 17, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 300 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 17, 2022

Gainers

Via Benzinga

NGM Bio To Highlight Updated Preliminary Findings From Advanced Solid Tumors Trial ↗

September 06, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022 ↗

October 18, 2022

Upgrades

Via Benzinga

Dow Looks To Reclaim Friday Losses As Stocks Rise ↗

October 17, 2022

Stocks are starting the week strong, extending this morning's gains at midday.

Via Talk Markets

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗

October 18, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

Via Benzinga

Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session ↗

October 17, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday.

Via Benzinga

How Is The Market Feeling About NGM Biopharmaceuticals? ↗

October 17, 2022

NGM Biopharmaceuticals's (NASDAQ:NGM) short percent of float has risen 23.05% since its last report. The company recently reported that it has 2.67 million shares sold short, which is 12.28% of all...

Via Benzinga

Nasdaq Jumps 300 Points; Bank of America Tops Q3 Estimates ↗

October 17, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Monday.

Via Benzinga

NGM Biopharmaceuticals, Fox Corporation And Some Other Big Stocks Moving Lower On Monday ↗

October 17, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

US Stocks Open Higher; Dow Surges 500 Points ↗

October 17, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 500 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 17, 2022

Gainers Acorda Therapeutics (NASDAQ:ACOR) shares increased by 46.1% to $0.49 during Monday's pre-market session. The company's market cap stands at $11.9 million.

Via Benzinga

NGM Bio Announces Topline Results from the CATALINA Phase 2 Trial of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

October 17, 2022

From NGM Biopharmaceuticals, Inc.

Via GlobeNewswire

NGM Bio to Host Conference Call to Discuss Topline Results from the CATALINA Phase 2 Trial of NGM621 in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration

October 16, 2022

From NGM Biopharmaceuticals, Inc.

Via GlobeNewswire

Poshmark, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

October 04, 2022

U.S. stock futures traded higher this morning after recording gains in the previous session. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket ↗

October 04, 2022

Gainers Bit Brother Limited (NASDAQ: BTB) rose 91.7% to $0.2150 in pre-market trading after declining around 14% on Monday.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

September 20, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

NGM Biopharmaceuticals's Return On Capital Employed Insights ↗

August 25, 2022

Benzinga Pro data, NGM Biopharmaceuticals (NASDAQ:NGM) reported Q2 sales of $8.29 million. Earnings fell to a loss of $46.52 million, resulting in a 43.36% decrease from last quarter.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Newport, VT (05855)

Today

Tonight

NGM Biopharmaceuticals, Inc. - Common Stock (NQ:NGM)

All News about NGM Biopharmaceuticals, Inc. - Common Stock